Titan Pharmaceuticals will be conducting two PROBUPHINE (buprenorphine) Implant REMS Training in Dallas, TX on Wednesday, July 24, 2019 from [1:00pm – 5:00pm and 6:00pm – 10:00pm]. Training is strictly limited to Physicians and Advanced Practice Providers (i.e., nurse practitioners and physician assistants). Healthcare providers are asked to review the REMS materials and the Full Prescribing Information before attending.
Healthcare providers may certify in one of the following three roles:
Prescriber: only prescribes buprenorphine implant (must have a DATA2000 waiver)
Surgical Procedure provider: only performs the buprenorphine implant insertion and removal surgical procedures
Dual provider: both prescribes and performs the buprenorphine implant insertion and removal surgical procedures.
No spouses or guests are permitted to attend any part of the training.